Skip to: Content
Skip to: Site Navigation
Skip to: Search
THURSDAY, NOVEMBER 26, 2009
| Subscribe to Newser's RSS feeds RSS | Follow Newser on Twitter Twitter

NEWS ABOUT: American College of Cardiology

American College of Cardiology stories: 3 news summaries

Drug May Cut Heart Attack Risk in Half

'Blockbuster' study could transform preventative care

Nov 9, 08 8:06 PM CST
(Newser) - A simple test and drug prescription can prevent hundreds of thousands of heart attacks and strokes, researchers say. Announced today at an American Heart Association meeting in New Orleans, the study of almost 18,000 volunteers in 26 nations confirmed that inflammation leads to heart disease—and can be counteracted... More »

MORE ABOUT:
heart disease • cholesterol • heart attack • statins • stroke • American Heart Association • drug trials • American College of Cardiology

 Clock Switch 
 May Be Good 
 for Ticker 

Heart attacks dip after clocks fall back

Oct 30, 08 5:30 AM CDT
(Newser) - Does turning clocks back in the autumn and forward in spring affect the risk of heart attack? New research suggests it may. Scientists found a 5% drop in heart attacks the day after clocks are changed in the fall, but discovered a 5% increase when clocks are moved ahead in... More »

MORE ABOUT:
sleep • heart attack • Daylight Saving Time • clocks • American College of Cardiology • Fall • Spring • National Board of Health and Welfare • Swedish Myocardial Infarction Register

2 Top Cholesterol Drugs, Vytorin and Zetia, Don't Work

Cardiologists urge prescribing statins over Vytorin, Zetia

Mar 31, 08 3:55 AM CDT
(Newser) - Two top-selling cholesterol drugs  proved in a recent study to be largely ineffective in slowing the clogging of arteries, a panel of cardiologists said yesterday. Doctors should only prescribe Vytorin and Zetia if other medications don't work, and should rely instead on statins such as Lipitor and Zocor, they said.... More »

MORE ABOUT:
cardiovascular disease • Merck • cholesterol • heart attack • cholesterol lowering drug • clinical trials • Vytorin • Zetia • American College of Cardiology • Schering-Plough

3 Stories


from our news partners